A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Center for Applied Technology Development Bookmark and Share

Sylvia R. and Isador A. Deutch Center for Applied Technology Development

City of Hope conducts basic research that produces valuable intellectual property, which is translated into new products, new businesses and new jobs.
 
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs. It also fosters commercial investment in the development of inventions and discoveries derived from research at City of Hope by licensing the relevant intellectual property. Through evaluation, marketing and licensing processes, CATD supports this goal by ensuring that technologies created at City of Hope are developed and commercialized for the benefit of the widest possible audience.
 
Among its many activities, CATD also hosts conferences for venture capitalists, at which City of Hope investigators present their findings to potential funding sources.
 
Our Office of Technology Licensing (OTL) actively pursues patent protection for new inventions devised by its investigators deemed of commercial importance. Further, the OTL licenses intellectual property (IP) via Internet marketing, targeted marketing and inquiries by outside interested parties.
 
The Center for Biomedicine & Genetics (CBG) is a premier academic facility specializing in rapid production of pharmaceutical-grade materials. CBG invites collaborators from other institutions and biopharmaceutical companies to test promising new therapeutics, and supports phase I and II clinical trials at City of Hope.
 
The Office of IND Development and Regulatory Affairs helps campus investigators interact with governmental regulatory agencies and remain in compliance with United States Food and Drug Administration requirements.
 
City of Hope is a designated Production Assistance for Cellular Therapies (PACT) facility. For additional information about this program, click on the link: www.pactgroup.net/
 
Partners and Contributors
City of Hope is deeply grateful to our partners whose contributions have made the  Center for Biomedicine & Genetics possible. In particular, we would like to thank the National Office Products Industry . In recognition of their generous gift to Center for Biomedicine and Genetics (CBG), the first floor of the CBG facility is named the Sylvia R. and Isador A. Deutch Center for Applied Technology Development.
 

Center for Applied Technology Development Staff

Center for Applied Technology Development

Sylvia R. and Isador A. Deutch Center for Applied Technology Development

City of Hope conducts basic research that produces valuable intellectual property, which is translated into new products, new businesses and new jobs.
 
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs. It also fosters commercial investment in the development of inventions and discoveries derived from research at City of Hope by licensing the relevant intellectual property. Through evaluation, marketing and licensing processes, CATD supports this goal by ensuring that technologies created at City of Hope are developed and commercialized for the benefit of the widest possible audience.
 
Among its many activities, CATD also hosts conferences for venture capitalists, at which City of Hope investigators present their findings to potential funding sources.
 
Our Office of Technology Licensing (OTL) actively pursues patent protection for new inventions devised by its investigators deemed of commercial importance. Further, the OTL licenses intellectual property (IP) via Internet marketing, targeted marketing and inquiries by outside interested parties.
 
The Center for Biomedicine & Genetics (CBG) is a premier academic facility specializing in rapid production of pharmaceutical-grade materials. CBG invites collaborators from other institutions and biopharmaceutical companies to test promising new therapeutics, and supports phase I and II clinical trials at City of Hope.
 
The Office of IND Development and Regulatory Affairs helps campus investigators interact with governmental regulatory agencies and remain in compliance with United States Food and Drug Administration requirements.
 
City of Hope is a designated Production Assistance for Cellular Therapies (PACT) facility. For additional information about this program, click on the link: www.pactgroup.net/
 
Partners and Contributors
City of Hope is deeply grateful to our partners whose contributions have made the  Center for Biomedicine & Genetics possible. In particular, we would like to thank the National Office Products Industry . In recognition of their generous gift to Center for Biomedicine and Genetics (CBG), the first floor of the CBG facility is named the Sylvia R. and Isador A. Deutch Center for Applied Technology Development.
 

Meet Our Staff

Center for Applied Technology Development Staff

Contact Us
For inquiries concerning the CBG manufacturing facility and collaborative opportunities please contact:
 
Larry A. Couture, Ph.D. or
David Hsu, Ph.D.
Center for Applied Technology Development
City of Hope
1500 E. Duarte Road
Duarte, CA 91010
626-256-8728
Center for Applied Technology Development (CATD)
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • We’ve all heard the mantra: Cancer screening saves lives. And it does, especially with colorectal cancer. Regular colonoscopies have been proven to reduce the risk of colorectal cancer death by up to 70 percent. Screening for colorectal cancer using the even simpler fecal occult blood tests has been found to re...
  • Pick up any biotech industry report and you’re guaranteed to come across one term repeatedly – CAR-T therapy. A fierce competition is now underway to bring CAR-T treatments to market – several companies (Juno, Novartis, Kite and Cellectis, to name a few) have major stakes in the race. I’ve found the CAR-T buzz ...
  • Patients undergoing treatment at City of Hope know they will be receiving the best medical care available, that their treatment will be delivered with compassion and that their care will extend to their families. “When we treat a patient here, we treat a family,” says Jo Ann S. Namm, child life manager and spec...
  • Did you know that colorectal cancer equally affects men and women? Or that it’s the third-leading cause of cancer death in the U.S.? Most important, did you know that colorectal cancer is very treatable and highly curable if detected early? If you didn’t know these facts, it’s time to learn. M...
  • To celebrate the beginning of Lunar New  Year 2015, City of Hope honored not just a new lunar calendar, but also the diversity of the community it serves. On Jan. 21, as tens of thousands of people celebrated Lunar New Year (and the arrival of the Year of the Ram) in the streets of L.A.’s Chinatown, City of [&#...
  • The breakthroughs that have revolutionized cancer treatment, transforming cancer in many cases to a very manageable and even curable disease, started out as just ideas. “I will often tell patients there’s no therapy we’re using to help them that wasn’t derived from somebody’s idea in some laboratory, working la...
  • The prostate cancer screening debate, at least as it relates to regular assessment of prostate specific antigen levels, is far from over. The U.S. Preventive Services Task Force recommended against routine PSA screening for prostate cancer in 2012, maintaining that the routine use of the PSA blood test does mor...
  • Cancer patients should get more than medical treatment. They should get comprehensive, evidence-based care that addresses their full range of needs. That kind of patient-focused care is City of Hope’s specialty. Under the guidance of Dawn Gross, M.D., Ph.D., the new Arthur M. Coppola Family Chair in Suppo...
  • Think twice before tossing out those hormone replacement pills. Although a new Lancet study suggests that hormone replacement therapy could increase a woman’s risk of ovarian cancer, a City of Hope expert urges women to keep this news in perspective. Hormone replacement therapy is prescribed to help allev...
  • Don’t know what to take, or send, that friend of yours in the hospital? Try a paper plate — filled not with cookies or sweets, but an image of yourself. Ilana Massi, currently undergoing treatment at City of Hope for acute myeloid leukemia, can vouch for the power of such a gift. She’s surrounded herself [̷...
  • With precision medicine now a national priority, City of Hope has joined a novel research partnership designed to further understanding of cancer at the molecular level, ultimately leading to more targeted cancer treatments. The Oncology Research Information Exchange Network, or ORIEN, is the world’s larg...
  • The spinal cord is an integral part of the human body, connecting the brain to everything else. So when a tumor grows on the spine, any messages that the brain tries to send to the rest of the body are interrupted, making everyday tasks — such as walking — more difficult. This year an estimated 22,850 […]
  • Each year, thousands of patients with hematologic malignancies undergo allogeneic stem cell transplantation (that is, they receive a donor’s stem cells), offering them a chance at cure. Graft-versus-host disease is a potentially deadly complication of this therapy and occurs in approximately 25 to 60 perc...
  • Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope, offers his perspective on the benefits of surgery for aggressive prostate cancer. For men walking out of the doctor’s office after a diagnosis of cancer, the reality can hit like a ton of bricks. Th...
  • Although many Hispanic women face a high risk of mutations in the BRCA1 and BRCA2 genes – increasing their risk of breast and ovarian cancer – screenings for these mutations can be prohibitively expensive in Mexico and other Latin American countries. As a result, too many women don’t get the information t...